MassDevice3d
FDA clears outpatient cardiac telemetry for SmartCardia ECG patch
SmartCardia announced today that it received FDA clearance for mobile outpatient cardiac telemetry (OCT/MCT) for its ECG ...
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
SmartCardia has received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring ...
Morningstar4d
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
LAUSANNE, Switzerland, Nov. 13, 2024 /PRNewswire/ -- SmartCardia has received FDA clearance for Mobile Outpatient Cardiac Telemetry (OCT/MCT) for its 7-lead live ECG monitoring patch and cloud ...
Mena FN3d
Smartcardia Receives FDA Clearance For Outpatient Cardiac Telemetry For Its 7-Lead ECG Patch And Cloud Platform
SmartCardia's patch and cloud platform is a single solution for complete cardiology practice: the patch can be used in any of the modes from holter to mobile telemetry and can also be remotely ...
Benzinga.com25d
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
The Zio AT device is a prescription-only outpatient cardiac telemetry device, commonly called a mobile cardiac telemetry device, used to provide mobile cardiac telemetry (MCT) services.
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
Detailed price information for Irhythm Technologies Inc (IRTC-Q) from The Globe and Mail including charting and trades.